| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 94,915 | 88,482 | 80,008 | 74,581 | | Cost of Revenue | 18,417 | 16,710 | 14,774 | 13,456 | | | Gross Profit | 76,498 | 71,772 | 65,234 | 61,125 | | | Operating Expenses | | Research Development | 10,654 | 9,200 | 10,193 | 6,146 | | Selling General and Administrative | 59,761 | 58,149 | 58,481 | 50,847 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,083 | 4,423 | (3,440) | 4,132 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (38) | (149) | 776 | (432) | | Earnings Before Interest And Taxes | 6,045 | 4,274 | (2,664) | 3,700 | | Interest Expense | 1,609 | 1,962 | 1,868 |
-
| | Income Before Tax | 4,436 | 2,312 | (4,532) | 3,700 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | 628 | 683 |
-
|
-
| | | | Net Income From Continuing Ops | 5,064 | 2,995 | (4,532) | 3,700 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,064 | 2,995 | (4,532) | 3,700 | | Preferred Stock And Other Adjustments |
-
| (230) | 230 |
-
| | | Net Income Applicable To Common Shares | $5,064 | $2,765 | ($4,302) | $3,700 |
|
0.01% Nasdaq 
Income Statement
